Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
IASLC WCLC 2026
2026 ASCO GI
ASCO Breakthrough 2026
ASCO 2026
ESTRO 2026
Calendar
View All
Topics
AI in Oncology
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Search Results
Advertisement
No results found for "Jasenka Piljac ��egarac, PhD"
Suggestions:
Ensure words are spelled correctly.
Try rephrasing keywords or using synonyms.
Try less specific keywords.
«
1
»
Advertisement
Advertisement
Sep
23
Today In Oncology
Excess Mortality Halts Trial of Venetoclax Added to DA-EPOCH-R in Double-Hit Lymphoma
Germline EGFR T790M Associated With Significant Lung Cancer Risk
Second-Line Investigational Monoclonal Antibody in Metastatic Squamous NSCLC
Neoadjuvant Anbenitamab/Chemotherapy Combination Improves Response in ERBB2-Positive Breast Cancer
ASCO Breakthrough Studies Target Supportive Care Problems That Can Derail Treatment
View More
Advertisement